 The purpose of this study is to evaluate the safety and efficacy of four times daily Positive Expiratory Pressure oPEP Aerobika maneuvers over three weeks in individuals with bronchiectasis and chronic obstructive pulmonary disease COPD with chronic sputum production. The investigators hypothesize that four times daily positive expiratory pressure using the Aerobika will significantly improve dyspnea, movement of mucus, St. Georges Respiratory Questionnaire SGRQ score, and six-minute walk distance 6MWD after three weeks of four times daily administration. 